gip vs glp-1 The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism GLP-1 Receptor Agonists – Peripheral
Description
Investigations persist into innovative delivery methods and formulations that may improve absorption, prolong duration of effect, or provide alternate routes of administration
Mast Cells and GLP-1 Receptors GLP1 receptors are present on many different cell types including mast cells
2023aRetatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Do I have any contraindications
So what is it
Most people also felt that weight-loss treatment ads put pressure on people to lose weight and often target vulnerable audiences
